Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET
Company Participants
Darren Fox - Executive Director of Investor Relations
Bruce Cozadd - Chairman and Chief Executive Officer
Dan Swisher - President and Chief Operating Officer
Rob Iannone - Executive Vice President, Global Head of R&D
Renee Gala - Executive Vice President and Chief Financial Officer
Kim Sablich - Executive Vice President and General Manager, United States
Conference Call Participants
Jessica Fye - J.P. Morgan
Marc Goodman - SVB Leerink
Jason Gerberry - Bank of America
Annabel Samimy - Stifel
David Amsellem - Piper Sandler
Gary Nachman - BMO
Balaji Prasad - Barclays
Gregory Renza - RBC
Brandon Folkes - Cantor Fitzgerald
Ash Verma - UBS
Ami Fadia - Needham & Company
Omari Baruti - Goldman Sachs
Greg Fraser - Truist
Operator
Good day, and welcome to the Jazz Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there'll be a question-and-answer session. Instructions will be given at that time. As a reminder, this call is being recorded.
I would now like to turn the call over to Darren Fox, Executive Director of Investor Relations. You may begin.
Darren Fox
Thank you, operator, and good afternoon, everyone.
Today, Jazz Pharmaceuticals reported its fourth quarter and full year 2022 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted on our website.
On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renee Gala, Executive Vice President and Chief Financial Officer; Dan Swisher, President and Chief Operating Officer; and Rob Iannone, Executive Vice President, Global Head of R&D. Kim Sablich, Executive Vice President and General Manager, United States, will join the team for Q&A.
On Slide 2, I'd like to remind you that today's webcast includes forward-looking statements, such as those related to our future financial and operating results, growth potential and anticipated developments and commercialization milestones and goals, which involve risks and uncertainties that could cause actual events, performance, and results to differ materially from those contained in these forward-looking statements.
We encourage you to review the statements contained in today's press release, in our slide deck, and in our latest SEC disclosure documents, which identify certain factors that may cause the company's actual events, performance, and results to differ materially from those contained in the forward-looking statements made on today's webcast. We undertake no duty or obligation to update our forward-looking statements.